Abstract:ObjectiveTo understand the usage of antibiotics in outpatients in a county of Zhejiang Province from 2015 to 2020， so as to provide a basis for further standardizing the clinical application of antibiotics in this region.MethodsOutpatient records and prescription records of 146 public medical institutions from 2015 to 2020 were extracted from the electronic medical record data sharing platform system of medical institutions in a county of Zhejiang Province. The utilization rates and the number of types of antibiotics used in outpatient patients were described. According to the drug anatomy， therapeutic and chemical classification system （ATC）， clinical application classification and dosage form， the use status of different types of antibiotics was observed. The annual percentage change （APC） was used to analyze the time trend of antibiotic use. Among the antibiotic prescriptions in each year， the proportions of prescriptions aimed for different use reasons and patients were compared to analyze the changes in the structures of antibiotic prescriptions.ResultsDuring 2015‒2020， a total of 2 861 438 prescriptions were issued in 146 primary public medical institutions in this county， including 314 642 prescriptions for antibiotics， and the overall utilization rate of antibiotics was 11%. The utilization rate of antibiotics showed a decreased trend across the years （from 14.23% in 2015 to 7.59% in 2020， APC=-11.51%， 95%CI=-0.01%‒-21.7%， t=-12.05， P<0.001） and an obvious seasonal variation character （higher in winter and spring， lower in summer and autumn）. Cefoxitin sodium for injection was the most used antibiotic in 2015， and cefuroxime was the most used antibiotic from 2015 to 2020， respectively. The utilization rates of cephalosporins （APC=-11.06%， 95%CI=0‒-20.89%， t=-22.233， P<0.001）， quinolones （APC=-9.74%， 95%CI=0‒-18.53%， t=-7.652， P=0.002）， macrolides （APC=-17.52%， 95%CI=0‒-17.52%， t=-3.626， P=0.022） and lincoamides （APC=-49.01%， 95%CI=0‒-74%， t=-3.35， P=0.029） showed a decreasing trend across the years. There were differences in the distribution of drug use reasons （χ2=9 458.427， P<0.001）， as well as the age （χ2=5 421.709， P<0.001） and sex （χ2=245.322， P<0.001） of patients. During the observation period， 50.69% of antibiotic prescriptions were used to treat respiratory diseases， with the highest proportion of 57.67% in 2015 and the lowest proportion of 34.93% in 2020. 58.37% of patients were aged 50‒70 years， with a decreasing proportion of patients under 50 years （17.83% in 2015， 6.64% in 2020） and an increasing proportion of patients over 70 years （24.1% in 2015， 38.41% in 2020）.ConclusionThe utilization rate of antibiotics used in outpatients from primary public medical institutions in a county of Zhejiang Province shows a decreasing trend across the years， but higher than that of secondary and above hospitals in China， and also higher than that of primary medical institutions in economically-developed areas. The management and monitoring of the clinical use of antibiotics in the county should be actively strengthened.

Analysis of Ribavirin Utilization Based on Yinzhou Healthcare Database

Utilization of Ribavirin Injection Among Reproductive Population Aged 18 to 44 Years Old Based on Yinzhou District Healthcare Database

Utilization of Intravenous Ribavirin Among Reproductive Age Adults in 2010-2017: A Population-Based Study in the Yinzhou District, Ningbo City of China

Epidemiological analysis of serum HBV DNA level among 13 039 patients with Hepatitis B

Utilization Study of Lipid-lowering Drugs in Hangzhou District

Analysis of the Safety and Benefit-risk of Ribavirin

Analysis on the Trend of Drug Use in 22 Hospitals in Hangzhou Region During the Period from 2002 to 2004

Therapeutic Drug Monitoring and Individualized Medication of Ribavirin

Analysis on Application of Anti-HBV Nucleoside ( acid ) Analogues Based on the Clinical Treatment of Hepatitis B in 302 Hospital of People' s Liberation Army During 2014-2016

Analysis of antiviral regimen in outpatients with chronic hepatitis B

Analysis of the Utilization of Commonly Used Quinolones in 35 Hospitals from Nanjing Area during the Period of 2009-2011

[Prevalence of Medicare Antiviral Drugs Use and Related Factors in HIV-infected People in Ningbo].

Changes of Inflammatory Cytokines/chemokines During Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin Therapy for Patients with Genotype 1b Hepatitis C Infection

Trend of Antibiotics Usage among Outpatients in Primary Public Medical Institutions in a County of Zhejiang Province， from 2015 to 2020

A high performance liquid chromatography method for the quantitative determination of ribavirin in human plasma and its application in a pharmacokinetics study

Pharmacokinetics of ribavirin tablets in healthy volunteers

Patients with chronic hepatitis C receiving sofosbuvir and ribavirin-based treatment, with or without interferon in Zhejiang, China: An observational study.

Efficacy of ribavirin and interferon-α therapy for hospitalized patients with COVID-19: A multicenter, retrospective cohort study

Safety and efficacy of ribavirin:A systematic review of meta-analysis results

有在有长期的丙肝的老病人的 peginterferon alpha-2a 和 ribavirin 的功效和因素影响治疗

Prevalence of inappropriate use of nirmatrelvir-ritonavir antiviral therapy in hospitalized patients: A multicenter retrospective study in China